Igs2em13(Alb-TTR*V50M)Gpt
Endonuclease-mediated Allele Detail
|
|
| Symbol: |
Igs2em13(Alb-TTR*V50M)Gpt |
| Name: |
intergenic site 2; endonuclease-mediated mutation 13, GemPharmatech Co., Ltd |
| MGI ID: |
MGI:7300626 |
| Synonyms: |
Igs2em1Cin(Alb- hTTR V50M luciferase) |
| Gene: |
Igs2 Location: Chr11:3195460-3195497 bp Genetic Position: Chr11, Syntenic
|
| Alliance: |
Igs2em13(Alb-TTR*V50M)Gpt page
|
|
|
|
| Allele Type: |
|
Endonuclease-mediated (Humanized sequence, Inserted expressed sequence, Reporter) |
| Mutation: |
|
Insertion
|
| |
|
Igs2em13(Alb-TTR*V50M)Gpt expresses
1 gene
Knock-in expresses:
| Organism |
Expressed Gene |
Homolog in Mouse |
Note |
| human |
TTR (7276) |
|
|
|
| |
|
Mutation details: CRISPR-targeting inserted the mouse promoter driving liver-specific expression of the human gene coding sequence with a mutation that results in the amino acid substitution of valine with methionine at position 50 (V50M). A luciferase reporter gene was also inserted into the locus.
(J:293217)
|
| Inheritance: |
|
Not Specified |
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Igs2 Mutation: |
69 strains or lines available
|
|
|
|